The small intestinal mucosal damage in coeliac disease is induced by gluten. The mechanism of the gluten induced injury is, however, unclear. Local antigen antibody reaction as well as cell mediated immune mechanisms have been implicated in the damage.' The possibility that dietary gluten may act as a lectin that is toxic to the jejunal mucosa in patients with coeliac disease has also been suggested.2 3 90 kDa Glycoprotein is a newly described tissue protein which accumulates extracellularly in the skin and to some extent in the gut in a rare hyalin disease, massive cutaneous hyalinosis. 
Methods

PATIENTS
Coeliac disease Thirty three patients, mean age 37 years (range 16 to 73 years), with coeliac disease were studied. The diagnosis was based on a characteristic jejunal lesion and subsequent satisfactory clinical and morphological response to gluten free diet. Pretreatment sera were available from all patients; in 13 patients sera were also available at the time of repeat biposy (mean time of gluten free diet nine months, range three to 36 months). Villous height was determined as described elsewhere. 6 Inflammatory bowel disease Thirty patients, mean age 31 years (range 20 to 54 years), with biopsy verified inflammatory bowel disease were studied. Fifteen of the patients had ulcerative colitis, and 15 Crohn's disease. In each patient serum samples were studied in an activephase of the disease and in remission. Immunoperoxidase staining Four ,um sections were cut from formalin-fixed, paraffin embedded blocks of human tissues obtained at surgery or as biopsy specimens. The tissue sections were rehydrated in a graded alcohol series and then washed in PBS. The intrinsic peroxidase activity was blocked with 0-3% H202 in methanol for 30 minutes. Rabbit antiserum to 90 kDa glycoprotein, immunoglobulins, or normal rabbit serum (50-fold diluted) were applied for 30 minutes. As a second layer peroxidase conjugated swine antirabbit serum (diluted 1:100) (Dakopatts, Copenhagen, Denmark) was used for 30 minutes. The sections were thereafter incubated for 10 minutes with 3' ,3'-diaminobenzidine tetrahydrochloride and H202 (DAB 0 5 mg/ml PBS, 0 003% H202) (Sigma, St Louis Mo.). The specimens were counterstained with haematoxylin and eosin; as well as with methyl green. Controls in the immunohistochemistry studies included omission of the primary antiserum and its replacement with normal rabbit serum. Sections of massive cutaneous hyalinosis skin was used as positive control.
ENZYME-LINKED IMMUNOSORBENT ASSAY OF ANTIBODIES TO 90 kDa GLYCOPROTFIN
Polystyrene tubes were coated with 90 kDa glycoprotein 1 ml of antigen solution (0.5 ug/ml) in 0-05 mol phosphate buffer, pH 7-3, with 0-05% NaN2. One ml of serum diluted 1:200 with phosphatebuffered saline containing 0-05% Tween 20, was added to each tube. The antibodies bound to 90 kDa glycoprotein were detected with alkaline phosphatase labelled antiserum to human immunoglobulins (Orion Diagnostica, Espoo, Finland). The amount of alkaline phosphatase fixed to the tubes was determined in diethanolamine buffer (pH 10 The epithelium of uterine cervix and trachea stained weakly in some sections. In the skin, bright staining was found in the basal cells of the hair follicle; specifically staining material was to some extent also located extracellularly (Fig. 1) . In the gut, a few lamina propria cells stained brightly (Fig. 2) 
x200 (original magnification).
disease there were no differences in antibody concentrations in sera obtained in the active phase of the disease or in remission.
After gluten withdrawal in coeliac patients antibody levels fell significantly (p<0-005, Fig. 3) . During therapy the decrease in anti-90 kDa glycoprotein antibody concentrations correlated with the decrease in IgA-antigliadin antibody levels (r=0-68, p<0-05). The levels of 90 kDa glycoprotein antibody did not significantly correlate with antireticulin antibody titres (r,=0-41, NS). Antibodies to different fractions of wheat proteins are frequently found in patients with coeliac disease. Antigluten and antigliadin antibodies are sensitive markers of gastrointestinal diseases, but are not specific for coeliac disease. 10 11 The IgA class antibodies to gliadin correlated with the anti-90 kDa glycoprotein antibody levels during the response to gluten withdrawal in the patients with coeliac disease. As our antiserum to 90 kDa glycoprotein is monospecific and does not react with gliadin or gluten, the possibility of cross reaction as an explanation for the findings is excluded. The decrease in the anti-90 kDa glycoprotein antibody levels was associated with a marked improvement of the jejunal mucosal changes. IgA antigliadin antibody levels reflect the mucosal injury, too, but in contrast with these antibodies, which may also be raised in Crohn's disease,1' the anti-90 kDa glycoprotein antibody concentrations were normal in active Crohn's disease as well as ulcerative colitis.
Although there exist some structural similarities between the 90 kDa glycoprotein and the noncollagenous component of reticulin,4 12 no clear relationship was found between the anti-90 kDa glycoprotein concentrations and antireticulin antibody titres. Firm conclusions about the relationship are difficult to draw, however, as reticulin antibodies were measured by a semiquantitative immunofluorescence technique.
Based on immunohistochemical evidence 90 kDa glycoprotein has a very limited distribution in normal human tissues. Skin and small intestinal mucosa as well as, possibly, the epithelium of uterine cervix and trachea, were the only of the tested tissues that specifically stained for 90 kDa glycoprotein. The strong staining of the basal cells of the hair follicle and of some of the intestinal lamina propria cells (distinct from plasma cells and macrophages) may indicate the cellular sites of synthesis of 90 kDa glycoprotein.
With regard to the pathogenesis of coeliac disease, and the inter-relationship between the gut and the skin,13 the tissue distribution of 90 kDa antigen is of interest. Interaction of dietary gluten with the intestinal mannose-rich 90 kDa glycoprotein, could result in antibody formation and in cytotoxicity, as shown for some other lectins.14 The presence of circulating antibodies to 90 kDa glycoprotein and to gliadin, and the relationship between their levels could thus be explained. As 
